Tempest Therapeutics Inc. (TPST)
undefined
undefined%
At close: undefined
0.95
-0.59%
After-hours Jan 03, 2025, 05:56 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Revenue n/a n/a n/a n/a n/a n/a 295.00K 653.00K 277.00K 9.73M n/a n/a n/a
Cost of Revenue 381.00K 1.81M 1.27M 815.00K 1.05M 32.00K 28.00K 5.40M 2.25M n/a n/a n/a n/a
Gross Profit -381.00K -1.81M -1.27M -815.00K -1.05M -32.00K 267.00K -4.75M -1.97M 9.73M n/a n/a n/a
Operating Income -29.16M -34.64M -26.99M -19.30M -45.40M -23.12M -20.48M -75.61M -72.00M -47.93M -29.13M -13.53M -2.62M
Interest Income 1.11M 549.00K 1.28K 90.00K 264.00K n/a n/a n/a n/a n/a n/a 19.00K n/a
Pretax Income -29.49M -35.71M -28.30M -19.21M -44.57M -27.18M -84.59M -82.06M -73.14M -49.52M -29.04M -13.51M -2.62M
Net Income -29.49M -36.78M -29.55M -19.12M -44.57M -27.19M -84.58M -82.26M -73.22M -49.52M -29.04M -13.51M -2.73M
Selling & General & Admin 11.66M 12.11M 9.82M 4.91M 16.50M 8.66M 5.93M 49.22M 51.59M 26.15M 13.33M 7.21M 1.45M
Research & Development 17.50M 22.53M 17.17M 14.39M 27.84M 14.43M 14.53M 21.64M 18.43M 21.78M 15.80M 6.32M 1.17M
Other Expenses n/a 549.00K -34.00K n/a n/a n/a 4.03M 5.40M n/a n/a n/a n/a n/a
Operating Expenses 29.16M 34.64M 26.99M 19.30M 44.35M 23.08M 20.45M 70.86M 70.03M 47.93M 29.13M 13.53M 2.62M
Interest Expense 1.45M 1.62M 1.28M n/a n/a 134.00K n/a 659.00K 436.00K n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a 16.50M -3.79M -21.82M n/a n/a n/a n/a n/a n/a
Cost & Expenses 29.16M 34.64M 26.99M 19.30M 45.40M 23.12M 20.48M 76.27M 72.28M 47.93M 29.13M 13.53M 2.62M
Income Tax n/a 1.07M 1.25M -90.00K 1K -169.00K 67.00K 201.00K 75.00K -1.59M 90.00K n/a n/a
Shares Outstanding (Basic) 15.42M 11.55M 3.79M 31.21K 913.78K 103.14K 1.17K 142.88K 120.38K 100.65K 100.65K n/a n/a
Shares Outstanding (Diluted) 15.42M 11.55M 3.79M 31.21K 913.78K 103.14K 1.17K 142.88K 120.38K 100.65K 100.65K n/a n/a
EPS (Basic) -1.91 -3.18 -7.8 -612.56 -48.77 -263.65 -72.41K -575.73 -608.25 -491.98 -288.55 -2.33 n/a
EPS (Diluted) -1.91 -3.18 -7.8 -612.56 -48.77 -263.65 -72.41K -575.73 -608.25 -491.98 -288.55 -2.33 n/a
EBITDA -28.78M -32.28M -25.72M -18.39M -43.52M -27.01M -84.27M -79.82M -71.86M -49.07M -28.81M -13.53M -2.62M
Depreciation & Amortization 381.00K 1.81M 1.27M 815.00K 1.05M 32.00K 28.00K 2.24M 1.29M 450.00K 231.00K n/a n/a